The Allele Burden of JAK2 Mutations Remains Stable Over Several Years in Patients With Myeloproliferative Disorders

Haematologica - Italy
doi 10.3324/haematol.13074
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Sex Differences in the JAK2V617F Allele Burden in Chronic Myeloproliferative Disorders

Haematologica
Hematology
2010English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

JAK2 p.V617F Allele Burden in Myeloproliferative Neoplasms One Month After Allogeneic Stem Cell Transplantation Significantly Predicts Outcome and Risk of Relapse

Haematologica
Hematology
2013English

MPL515 Mutations in Myeloproliferative and Other Myeloid Disorders: A Study of 1182 Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Classification of Myeloproliferative Disorders in the JAK2 Era: Is There a Role for Red Cell Mass?

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

The C Allele of JAK2 Rs4495487 Is an Additional Candidate Locus That Contributes to Myeloproliferative Neoplasm Predisposition in the Japanese Population

BMC Medical Genetics
Genetics
2012English

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri Population

Asian Pacific Journal of Cancer Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy